KITLG and colorectal carcinoma: Several angiogenesis-related factors, such as IL-8, soluble angiopoietin II (sANG-2), basic FGF (b-FGF), and stem cell factor (SCF), have been shown to be increased in CRC patients that did not respond to bevacizumab.